-
David Salom
From the Departments of Ophthalmology and
the Biomedical Network Research Centre on Rare Diseases (CIBERER), Valencia, Spain;
-
Manuel Diaz-Llopis
From the Departments of Ophthalmology and
the Biomedical Network Research Centre on Rare Diseases (CIBERER), Valencia, Spain;
the Department of Ophthalmology of the Valencia University, Valencia, Spain;
the Superior Ophthalmology Centre of the Valencian Community, Mediterranean Ophthalmology Foundation, Valencia, Spain;
-
Arturo Quijada
the Department of Ophthalmology of the Valencia University, Valencia, Spain;
-
Salvador García-Delpech
From the Departments of Ophthalmology and
the Biomedical Network Research Centre on Rare Diseases (CIBERER), Valencia, Spain;
the Department of Ophthalmology of the Valencia University, Valencia, Spain;
Department of Ophthalmology, Catholic University San Vicente Martir, Valencia, Spain;
-
Patricia Udaondo
From the Departments of Ophthalmology and
the Biomedical Network Research Centre on Rare Diseases (CIBERER), Valencia, Spain;
-
F. Javier Romero
the Superior Ophthalmology Centre of the Valencian Community, Mediterranean Ophthalmology Foundation, Valencia, Spain;
the Department of Pharmacology Physiology and Neurotoxicology of the Cardenal Herrera-CEU University, Valencia, Spain; and
-
Jose Maria Millan
Genetics, La Fe University Hospital of Valencia, Valencia, Spain;
the Biomedical Network Research Centre on Rare Diseases (CIBERER), Valencia, Spain;
-
J. Fernando Arevalo
the Clinica Oftalmologica Centro Caracas, Retina and Vitreous Service, Caracas, Venezuela.